OS9 Antikörper (AA 232-413) (Biotin)

Produktnummer ABIN7165900

Produktdetails anti-OS9 Antikörper (Biotin)

Target: OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))

Bindungsspezifität: AA 232-413

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser OS9 Antikörper ist konjugiert mit Biotin

Applikation: ELISA

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Protein OS-9 protein (232-413AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu OS9

Target: OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))

Andere Bezeichnung: OS9 (OS9 Produkte)

Hintergrund:

Background: Lectin which functions in endoplasmic reticulum (ER) quality control and ER-associated degradation (ERAD). May bind terminally misfolded non-glycosylated proteins as well as improperly folded glycoproteins, retain them in the ER, and possibly transfer them to the ubiquitination machinery and promote their degradation. Possible targets include TRPV4.

Aliases: Amplified in osteosarcoma 9 antibody, amplified in osteosarcoma antibody, ERLEC2 antibody, OS-9 antibody, Os9 antibody, OS9_HUMAN antibody, Osteosarcoma amplified 9 endoplasmic reticulum lectin antibody, Protein OS-9 antibody

UniProt: Q13438

Pathways: Maintenance of Protein Location, SARS-CoV-2 Protein Interaktom